In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriaminepentaacetic acid

Antiviral Research

Volumn 31, Issue 1-2, 1996, Pages 23-34

  Cinatl Jr , J ^a   Hoffmann, F ^b   Cinatl, J ^a,b   Weber, B ^a   Scholz, M ^b   Rabenau, H ^a   Stieneker, F ^b   Kabickova, H ^c   Blasko, M ^a   Doerr, H W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c Clinical Laboratories Stresovice   (Czech Republic)

Author keywords

2,2' Bipyridine; Chelators; Desferrioxamine; Diethylenetriaminepentaacetic acid; Human cytomegalovirus

Indexed keywords

2,2' BIPYRIDINE; ANTIRON; ANTIVIRUS AGENT; CHELATING AGENT; DEFEROXAMINE; DEFEROXAMINE MESYLATE; PENTETATE CALCIUM TRISODIUM; PENTETIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; ULTRASTRUCTURE; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0029949334     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00833-0     Document Type: Article

References (41)

1. Aisen, P. and Listowsky, I. (1980) Iron transport and storage proteins. Annu. Rev. Biochem. 49, 357-393.
2. 2 + dependence of DNA synthesis in untransformed and in Ha-ras(val-12)-expressing NIH 3T3 cells. Exp. Cell Res. 208, 303-310.
3. Braun, W. and Schacherer, C. (1988) Rapid 24 (h) neutralization assay for the detection of antibodies to human cytomegalovirus using a monoclonal antibody to an HCMV early nuclear protein. J. Virol. Meth. 22, 31-40.
4. Bridges, K.R. and Cudkowicz, A. (1984) Effect of iron chelators on the transferrin receptor in K562 cells. J. Biol. Chem. 259, 12970-12977.
5. Catsch, A. and Hartmuth-Hoene, A.E. (1975) New developments in metal antidotal properties of chelating agents. Biochem. Pharmacol. 24, 1557-1562.
6. Chesters, J.K. (1992) Trace element-gene interactions. Nutr. Rev. 50, 217-223.
7. Cinatl, J., Jr., Cinatl, J., Rabenau, H., Gümbel, H.O., Kornhuber, B. and Doerr, H.W. (1994) In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res. 25, 73-74.
8. Cinatl, J., Jr., Scholz, M., Weber, B., Cinatl, J., Rabenau, H., Markus, B.H., Encke, A. and Doerr, H.W. (1995) Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transplant Immunol. 3, 313-320.
9. Cleton, F., Turnbull, A., Finch, C.A., Thompson, L. and Martin, J. (1963) Synthetic chelating agents in iron metabolism. J. Clin. Invest. 42, 327-3337.
10. Collaborative DHPG Treatment Study Group (1986) Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. N. Engl. J. Med. 314, 801-805.
11. Erice, A., Jordan, C., Chace, B., Fletcher, C., Chinnock, B.J. and Balfour H.H., Jr. (1987) Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts. J. Am. Med. Assoc. 257, 3082-3087.
12. Felsenstein, D., D'Amico, D.J., Hirsch, M.S., Neumeyer, D.A., Cederberg, D.M., de Miranda, P. and Schooley, R.T. (1985) Treatment of cytomegalovirus retinitis with 9-(2-hydroxy-1-(hydroxymethyl)propoxymethyl)guanine. Ann. Intern. Med. 103, 377-380.
13. Grefte, A., van der Giessen, M., van Son, W. and The, T.H. (1993). Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J. Infect. Dis. 167, 270-277.
14. Hamzeh, F.M., Spector, T. and Lietman, P.S. (1993) 2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]thiocarbonohydrazone (1110U81) potently inhibits human cytomegalovirus replication and potentiates the antiviral effects of ganciclovir. Antimicrob. Agents Chemother. 37, 602-604.
15. Hecht, D.W., Snydman, D.R., Crumpacker, C.S., Werner, B.G., Heinze-Lacey, B. and Boston Renal Transplant CMV Study Group. (1988) Ganciclovir for treatment of renal-transplant-associated primary cytomegalovirus pneumonia. J. Infect. Dis. 157, 187-190.
16. Hefner, L.J. and Storey, B.T. (1981) The role of calcium in maintaining motility in mouse spermatozoa. J. Exp. Zool. 218, 427-434.
17. Huang, E.S. and Kowalik, T.F. (1993) The pathogenicity of human cytomegalovirus: an overview. In: Y. Becker, G. Darai, and E.S. Huang (Eds.), Molecular Aspects of Human Cytomegalovirus Diseases. Frontiers of Virology, 2, Springer-Verlag, Berlin, pp. 3-45.
18. Jaffe, E.A., Nachman, R.L., Becker, C.G. and Minick, C.R. (1973) Culture of endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 52, 2745-2756.
19. Kar, L., Matsumura, P. and Johnson, M.E. (1992) Bivalent-metal binding to CheY protein. Effect on protein conformation. Biochem. J. 287, 521-531.
20. Knox, K., Dobryski, W. and Carrigan, D. (1991) Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet 337, 1292-1293.
21. Laskin, O.L., Stahl-Bayliss, C., Kalman, C.M. and Rosecan, L.R. (1987) Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS. J. Infect. Dis. 155, 323-327.
22. Lücke-Huhle, C. (1976) Proliferation-dependent cytotoxicity of diethylenetriamine-pentaacetate (DTPA) in vitro. Health Phys. 31, 349-354.
23. Muller-Eberhard, U., Erlandson, M.E., Glinn, H.E. and Smith, C.H. (1963) Effect of trisodium calcium diethylenetriaminepentaacetate on bivalent cations in thalassemia major. Blood 22, 209-217.
24. Myerson, D., Hackman, R.C., Nelson, J.A., Ward, D.C. and McDougall, J.K. (1984). Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15, 430-439.
25. Nunez, M.T., Cole, E.S. and Glass, J. (1983) The reticulocyte plasma membrane pathway of iron uptake as determined by the mechanism of alpha, alpha' dipyridyl inhibition. J. Biol. Chem. 258, 1146-11151.
26. Peters, G., Keberle, H., Schmid, K. and Brunner, H. (1966) Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem. Pharmacol. 15, 93-109.
27. Pippard, M.J. and Callender, S.T. (1983) The management of iron chelation therapy. Br. J. Haematol. 54, 503-507.
28. Pippard, M.J., Jackson, M.J., Hoffman, K., Petrou, M. and Modell, C.B. (1986) Iron chelation using subcutaneous infusion of diethylene triamine penta-acetic acid (DTPA). Scand. J. Haematol. 36, 466-472.
29. Polson, R.J., Jawed, A., Bomford, A., Berry, H. and Williams, R. (1985) Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects. Br. Med. J. (Clin. Res.) 291, 448.
30. Porter, D.J., Harrington, J.A. and Spector, T. (1990) Herpes simplex type 1 ribonucleotide reductase: selective and synergistic inactivation 11108U81 and its iron complex. Biochem. Pharmacol. 39, 639-646.
31. Sillén, L.G. and Martell, A.E. (1971) Stability Constants of Metal-Ion Complexes, Suppl. 1, The Chemical Society, London, pp. 728-730.
32. Singer, D.R.J., Fallon, T.J., Schulenburg, W.E., Williams, G. and Cohen, J. (1985) Foscarnet for cytomegalovirus retinitis. Ann. Intern. Med. 103, 962.
33. Spector, T., Harrington, J.A., Morrison, R.W., Jr., Lambe, C.U., Nelson, D.J., Averett, D.R., Biron, K. and Furman, P.A. (1989) 2-Acetylpyridine 5-[(dimethylamino)-thiocarbonyl]thiocarbono-hydrazon (1110U81), a potent inactivator of ribonucleotide reductase of herpes simplex and varicella-zoster viruses and a potentiator of a acyclovir. Proc. Natl. Acad. Sci. USA 86, 1051-1055.
34. Stanat, S.C., Reardon, J.E., Erice, A., Jordan, M.C., Drew, W.L. and Biron, K.K. (1991) Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir. Antimicrob. Agents Chemother. 35, 2191-2197.
35. Tatarowicz, W.A., Lurain, N.S. and Thompson, K.D. (1992) A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J. Infect. Dis. 166, 904-907.
36. Taylor, D.M. and Jones, J.D. (1972) Effects of ethylenetriaminepentaacetate on DNA synthesis in kidney and intestinal mucosa of folate treated rats. Biochem. Pharmacol. 21, 3312-3315.
37. Toorkey, C.B. and Carrigan, D.R. (1989). ImmunoHistochemical detection of an immediate early antigen of human cytomegalovirus in normal tissues. J. Infect. Dis. 160, 741-745.
38. Walmsley, L.L., Chew, E., Read, S.E., Vellend, H., Salit, I., Rachlis, A. and Fanning, M.M. (1988) Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet). J. Infect. Dis. 157, 569-572.
39. Waxman, H.S. and Brown, E.B. (1969) Clinical usefulness of iron chelating agents. Prog. Hematol. 6, 338-373.
40. 3DTPA. Arch. Dis. Child. 64, 77-82.
41. Youle, M.S., Clarbour, J., Gazzard, B. and Chanas, A. (1988) Severe hypocalcemia in AIDS patients treated with PFA and pentamidine. Lancet i, 14555-14556.